See every side of every news story

Published 17 days ago • loading... • Updated 17 days ago

Baricitinib may improve effect of narrowband UV-B in vitiligo

Summary by Deutsches Ärzteblatt

Bordeaux – A combination of phototherapy with narrowband UV-B radiation and the JAK inhibitor baricitinib could improve outcomes in extensive, active vitiligo. This is suggested by the results of a study in JAMA Dermatology (2025; DOI:...

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Deutsches Ärzteblatt

Baricitinib may improve effect of narrowband UV-B in vitiligo

Bordeaux – A combination of phototherapy with narrowband UV-B radiation and the JAK inhibitor baricitinib could improve outcomes in extensive, active vitiligo. This is suggested by the results of a study in JAMA Dermatology (2025; DOI:...

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated16 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in 17 days ago on Friday, February 7, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics